These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16479515)

  • 21. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.
    Lin W; Zhu C; Hong J; Zhao L; Jilg N; Fusco DN; Schaefer EA; Brisac C; Liu X; Peng LF; Xu Q; Chung RT
    J Hepatol; 2015 May; 62(5):1024-32. PubMed ID: 25481564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-inducible Protein 6-16 (IFI-6-16, ISG16) promotes Hepatitis C virus replication in vitro.
    Chen S; Li S; Chen L
    J Med Virol; 2016 Jan; 88(1):109-14. PubMed ID: 26105982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of silent information regulator-1 in hepatocytes induces lipid metabolism disorders and enhances hepatitis C virus replication].
    Sun LJ; Zhao YH; Li SC; Yu JW; Kang P; Liu W
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):834-9. PubMed ID: 24331693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism.
    Lee J; Tian Y; Chan ST; Kim JY; Cho C; Ou JH
    PLoS Pathog; 2015 May; 11(5):e1004937. PubMed ID: 26023919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphine withdrawal enhances hepatitis C virus replicon expression.
    Wang CQ; Li Y; Douglas SD; Wang X; Metzger DS; Zhang T; Ho WZ
    Am J Pathol; 2005 Nov; 167(5):1333-40. PubMed ID: 16251417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.
    Abe K; Ikeda M; Dansako H; Naka K; Shimotohno K; Kato N
    Virus Res; 2005 Jan; 107(1):73-81. PubMed ID: 15567036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon.
    Liu S; Hao Q; Peng N; Yue X; Wang Y; Chen Y; Wu J; Zhu Y
    Hepatology; 2012 Jul; 56(1):57-66. PubMed ID: 22318991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells.
    Fillebeen C; Muckenthaler M; Andriopoulos B; Bisaillon M; Mounir Z; Hentze MW; Koromilas AE; Pantopoulos K
    J Hepatol; 2007 Jul; 47(1):12-22. PubMed ID: 17399844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity.
    Liu C; Zhu H; Tu Z; Xu YL; Nelson DR
    Hepatology; 2003 Jun; 37(6):1335-42. PubMed ID: 12774012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon.
    Takahashi H; Okai Y; Paxton RJ; Hefta LJ; Shively JE
    Cancer Res; 1993 Apr; 53(7):1612-9. PubMed ID: 8453631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Dharel N; Kato N; Muroyama R; Taniguchi H; Otsuka M; Wang Y; Jazag A; Shao RX; Chang JH; Adler MK; Kawabe T; Omata M
    Hepatology; 2008 Apr; 47(4):1136-49. PubMed ID: 18220274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of hepatitis C virus replication by interferon regulatory factor 1.
    Kanazawa N; Kurosaki M; Sakamoto N; Enomoto N; Itsui Y; Yamashiro T; Tanabe Y; Maekawa S; Nakagawa M; Chen CH; Kakinuma S; Oshima S; Nakamura T; Kato T; Wakita T; Watanabe M
    J Virol; 2004 Sep; 78(18):9713-20. PubMed ID: 15331704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo.
    Spandau UH; Toksoy A; Verhaart S; Gillitzer R; Kruse FE
    Arch Ophthalmol; 2003 Jun; 121(6):825-31. PubMed ID: 12796254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
    Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
    Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
    Jia YT; Wei L; Jiang D; Cong X; Fei R
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon.
    Fang C; Yi Z; Liu F; Lan S; Wang J; Lu H; Yang P; Yuan Z
    Proteomics; 2006 Jan; 6(2):519-27. PubMed ID: 16317778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines.
    Ye F; Xin Z; Han W; Fan J; Yin B; Wu S; Yang W; Yuan J; Qiang B; Sun W; Peng X
    PLoS One; 2015; 10(11):e0142082. PubMed ID: 26544179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.
    Namba K; Naka K; Dansako H; Nozaki A; Ikeda M; Shiratori Y; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 2004 Oct; 323(1):299-309. PubMed ID: 15351737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.